organ transplant
CareDx to Study AlloSure Kidney for Routine Organ Transplant Surveillance in Pediatric Patients
The company is teaming up with the North American Pediatric Renal Trials and Collaborative Studies organization to study the long-term impact of AlloSure.
NGeneBio Gets CE-IVD Mark for HLA Typing Assay
The South Korean company said it now intends to begin expanding into international markets for HLA testing, beginning with Europe.
The company has signed a deal with Aarhus University that gives it access to a 40,000-sample biobank of patients who were screened for colorectal cancer.
Genome Diagnostics Makes €1M Investment in CRISPR Diagnostics Startup Scope Biosciences
A spinout of Wageningen University & Research, Scope Biosciences is developing a CRISRP-based diagnostics technology aimed at infectious diseases.
The firm is aiming to create pan-organ transplant services that connect patients to doctors throughout the transplant and recovery process.
Jul 13, 2021
Natera Inks Distribution Deal With TomaLab for Italy
Feb 25, 2021
Feb 24, 2021
CareDx Q4 Revenues Up 64 Percent
Jan 21, 2021
CareDx Prices $175M Common Stock Offering
Oct 29, 2020